Fibrinogen C-terminal peptidic sequences (Haptides) modulate fibrin polymerization

Gerard Marx; Matti Ben-Moshe; Sholomo Magdassi; Raphael Gorodetsky

doi:10.1160/TH03-05-0277

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2004; 91(01): 43-51
DOI: 10.1160/TH03-05-0277

Blood Coagulation, Fibrinolysis and Cellular Haemostasis

Schattauer GmbH

Fibrinogen C-terminal peptidic sequences (Haptides) modulate fibrin polymerization

Authors

Gerard Marx

¹HAPTO Biotech (Israel) Ltd., Jerusalem, Israel
Matti Ben-Moshe

²Cassali Institute of Applied Chemistry, Hebrew University, Jerusalem, Israel
Sholomo Magdassi

²Cassali Institute of Applied Chemistry, Hebrew University, Jerusalem, Israel
Raphael Gorodetsky

³Laboratory of Radiobiology and Biotechnology, Sharett Institute of Oncology, Hadassah University Hospital, Jerusalem, Israel

Abstract

Summary

We previously described synthetic peptides of 19-21 amino acid residues, homologous to the C-termini of fibrinogen Fib₃₄₀ and Fib₄₂₀, from the β-chain (Cβ), the extended αE chain (CαE) and near the end of the γ-chain (preCγ) which elicited attachment (haptotactic) responses from mesenchymal cells. We named these haptotactic peptides -Haptides. The effects of Haptides on fibrin clot formation was evaluated and their possible effects on platelet aggregation was examined. The Haptides Cβ, CαE and preCγ, (2-10 μM) increased fibrin clot turbidity and also decreased thrombin-induced clotting time. Higher concentrations (>120 μM of Cβ or preCγ) induced fibrinogen precipitation even without thrombin. These precipitates exhibited different ultrastructure from thrombin-induced fibrin by scanning and transmission microscopy. C-terminal peptides of the other fibrinogen chains exerted no such effects. Sepharose beads covalently coated with either whole fibrinogen or Haptides (SB-Fib or SB-Haptide) highly adsorbed free FITCHaptides. In aqueous solution, Haptides formed nano-particles with average size of ∼150nm in diameter. We suggest that such positively charged aggregates could serve to nucleate and accelerate fibrin gel formation. These results also indicate that Cβ and preCγ sequences within fibrin(ogen) participate in the docking and condensation of fibrin(ogen) during its assembly into a fibrin clot. By contrast, Haptides up to 100µM did not bind to platelets, and had no effect on platelet aggregation. Our findings highlight the roles of the C-terminal sequences of the β and γ chains in fibrin(ogen) polymerization as well as in cell attachment.

Keywords

Fibrinogen - turbidity - Haptides - coagulation - aggregate

Full Text

References

References
1 Nieuwenhuizen W, Mosesson MW, DeMaat MPM. Eds. Fibrinogen Workshop. Ann NY Acad Sci. 2001. 936 28-43.
2 Pratt KP, Cote HC, Chung DW. et al. The primary fibrin polymerization pocket: Threedimensional structure of a 30-kDa C-terminal gamma chain fragment complexed with the peptide Gly-Pro-Arg-Pro. Proc Natl Acad Sci USA 1997; 94: 7176-81.
3 Everse SJ, Spraggon G, Doolittle RF. A threedimensional consideration of variant human fibrinogens. Thromb Haemost 1998; 80: 1-9.
4 Chen CS, Chou SH, Thiagarajan P. Fibrin(ogen) peptide Bb15-42 inhibits platelet aggregation and fibrinogen binding to activated platelets. Biochemistry 1988; 27: 6121-6.
5 Muller B, Zerwes HG, Tangemann K. et al. Two-step binding mechanism of fibrinogen to αIIβ3 integrin reconstituted planar lipid bilayers. J Biol Chem 1993; 268: 6800-8.
6 Skarja GA, Brash JL, Bishop P. et al. Protein and platelet interactions with thermally denatured fibrinogen and cross-linked fibrin coated surfaces. Biomaterials 1998; 19: 2129-38.
7 Farrell DH, Thiagarajan P, Chung DW, Davie EW. Role of fibrinogen α and γ chain sites in platelet aggregation. Proc Natl Acad Sci USA 1992; 89: 10729-32.
8 Smith JW, Ruggeri ZM, Kunicki TJ. et al. Interaction of integrins αvβ3 and glycoproteins IIb-IIIa with fibrinogen. J Biol Chem 1990; 265: 12267-71.
9 Hantgan RR. Fibrin protofibril and fibrinogen binding to ADP-stimulated platelets: Evidence for a common mechanism. Biochim Biophys Acta 1988; 968: 24-35.
10 Yakovlev S, Litvinovich S, Loukinov D. et al. Role of the β-strand insert in the central domain of fibrinogen γ-module. Biochemistry 2000; 39: 15721-9.
11 Hsieh K. Localization of an effective fibrin beta-chain polymerization site: Implications for the poly amino acid ization mechanism. Biochemistry 1997; 36: 9381-7.
12 Horwitz BH, Varadi A, Scheraga HA. Localization of a fibrin γ-chain polymerization site within the segment Thr374 to Glu-396 of human fibrinogen. Proc Natl Acad Sci USA 1984; 81: 5980-4.
13 Olexa SA, Budzynski AZ. Localization of a fibrin polymerization site. J Biol Chem 1981; 256: 3544-9.
14 Grieninger G. Contribution of the αE C domain to the structure and function of fibrinogen-420. Ann NY Acad Sci 2001; 936: 44-64.
15 Marx G. Modelling cation-driven (proto)fibrin coagulation. Biopolymers 1988; 27: 763-74.
16 Marx G, Harari N. 1989 Albumin indirectly modulates (proto)fibrin ultrastructure. Biochemistry 1989; 28: 8242-8.
17 Yang Z, Pandi L, Doolittle RF. The crystal structure of fragment double-D from crosslinked lamprey fibrin reveals isopeptide linkages across an unexpected D-D interface. Biochemistry 2002; 41: 15610-7.
18 Doolittle RF, Yang Z, Mochalkin I. Crystal structure studies on fibrinogen and fibrin. Ann N Y Acad Sci 2001; 936: 31-43.
19 Siebenlist KR, Meh DA, Mosesson MW. Position of gamma-chain carboxy-terminal regions in fibrinogen/fibrin cross-linking mixtures. Biochemistry 2000; 39: 14171-5.
20 Okumura N, Furihata K, Terasawa F. et al. Fibrinogen Matsumoto I: a gamma 364 Asp → His (GAT → CAT) substitution associated with defective fibrin polymerization. Thromb Haemost 1996; 75: 887-91.
21 Lounes KC, Soria C, Mirshahi SS. et al. Fibrinogen Ales: a homozygous case of dysfibrinogenemia (gamma-Asp(330) → Val) characterized by a defective fibrin polymerization site “a”. Blood 2000; 96: 3473-9.
22 Okumura N, Gorkun OV, Lord ST. Severely impaired polymerization of recombinant fibrinogen gamma-364 Asp → His, the substitution discovered in a heterozygous individual. J Biol Chem 1997; 272: 29596-601.
23 Sugo T, Nakamikawa C, Yoshida N. et al. End-linked homodimers in fibrinogen Osaka VI with a beta-chain extension lead to fragile clot structure. Blood 2000; 96: 3779-85.
24 Brennan SO, Wyatt JM, Ockelford P. et al. Defective fibrinogen polymerization associated with a novel gamma 279Ala>Asp mutation. Br J Haematol 2000; 108: 236-40.
25 Gorodetsky R, Vexler A, An J. et al. Haptotactic and growth stimulatory effects of fibrin(ogen) and thrombin on cultured fibroblasts. J Lab Clin Med 1998; 131: 269-80.
26 Gorodetsky R, Vexler A, Shamir M, An J. et al. Fibrin microbeads (FMB) as biodegradable carriers for culturing cells and for accelerating wound healing. J Invest Dermatol 1999; 112: 866-72.
27 Gurevich O, Vexler A, Marx G. et al. Fibrin microbeads (FMB) for isolating and growing bone marrow-derived progenitor cells capable of forming bone tissue. Tissue Eng 2002; 08: 661-72.
28 Gorodetsky R, Vexler A, Shamir M. et al. New cell attachment peptide sequences from conserved epitopes in the carboxy termini of fibrinogen. Exper Cell Res 2003; 287: 116-29.
29 Hansen FK, Hveem J. The interfacial tension between acrylic monomers and polymers and non-ionic surfactants investigated by the automatic sessile drop method. J Colloid Interface Sci 1999; 210: 144-51.
30 Maeda H, Kishi T, Ikeda S. The precipitation of human fibrinogen by zinc chloride. Bull Soc Jpn 1983; 56: 1351-6.
31 Marx G, Eldor A. Pro-coagulant effect of zinc on thrombin-induced fibrin clot formation. Amer J Hematol 1985; 19: 151-9.
32 Marx G, Gurfel D, Hopmeier P. Zinc alters fibrin ultrastructure. Thromb Haemost 1987; 57: 73-6.